Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection

• Autores principales: Abdelrahim Maen (Autor), Betul Gok Yavuz (Autor), Yehia I. Mohamed (Autor), Abdullah Esmail (Autor), Jianming Lu (Autor), Amr Mohamed (Autor), Asfar S. Azmi (Autor), Mohamed Kaseb (Autor), Osama Kasseb (Autor), Dan Li (Autor), Michelle Gocio (Autor), Mehmet Kocak (Autor), Abdelhafez Selim (Autor), Qing Ma (Autor), Ahmed O. Kaseb (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2024-02-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Thymoquinone TQ, an active ingredient of Nigella Sativa, has been shown to inhibit COVID-19 symptoms in clinical trials. Thymoquinone Formulation (TQF or NP-101) is developed as a novel enteric-coated medication derivative from Nigella Sativa. TQF consists of TQ with a favorable concentration and fa...